345 related articles for article (PubMed ID: 25174607)
21. Caffeine induces a second wave of apoptosis after low dose-rate gamma radiation of HL-60 cells.
Vávrová J; Mareková-Rezácová M; Vokurková D; Szkanderová S; Psutka J
Radiat Environ Biophys; 2003 Oct; 42(3):193-9. PubMed ID: 14569403
[TBL] [Abstract][Full Text] [Related]
22. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo.
Liu Y; Cui B; Qiao Y; Zhang Y; Tian Y; Jiang J; Ma D; Kong B
Int J Gynecol Cancer; 2011 Jan; 21(1):100-5. PubMed ID: 21330835
[TBL] [Abstract][Full Text] [Related]
23. Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.
Raleigh DR; Haas-Kogan DA
Future Oncol; 2013 Feb; 9(2):219-33. PubMed ID: 23414472
[TBL] [Abstract][Full Text] [Related]
24. Role of metabolism in cancer cell radioresistance and radiosensitization methods.
Tang L; Wei F; Wu Y; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Deng H; Cao K; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
J Exp Clin Cancer Res; 2018 Apr; 37(1):87. PubMed ID: 29688867
[TBL] [Abstract][Full Text] [Related]
25. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.
Ding M; Zhang E; He R; Wang X
Cancer Sci; 2013 Nov; 104(11):1401-10. PubMed ID: 23930697
[TBL] [Abstract][Full Text] [Related]
26. Radiosensitization by PARP inhibition to proton beam irradiation in cancer cells.
Hirai T; Saito S; Fujimori H; Matsushita K; Nishio T; Okayasu R; Masutani M
Biochem Biophys Res Commun; 2016 Sep; 478(1):234-240. PubMed ID: 27425251
[TBL] [Abstract][Full Text] [Related]
27. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
28. Poly (ADP-ribose) polymerase inhibitor, an effective radiosensitizer in lung and pancreatic cancers.
Hastak K; Bhutra S; Parry R; Ford JM
Oncotarget; 2017 Apr; 8(16):26344-26355. PubMed ID: 28412751
[TBL] [Abstract][Full Text] [Related]
29. MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.
Moretti L; Niermann K; Schleicher S; Giacalone NJ; Varki V; Kim KW; Kopsombut P; Jung DK; Lu B
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1189-97. PubMed ID: 21514073
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy.
Kim BM; Hong Y; Lee S; Liu P; Lim JH; Lee YH; Lee TH; Chang KT; Hong Y
Int J Mol Sci; 2015 Nov; 16(11):26880-913. PubMed ID: 26569225
[TBL] [Abstract][Full Text] [Related]
31. Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule.
Heravi M; Rachid Z; Goudarzi A; Schlisser A; Jean-Claude BJ; Radzioch D; Muanza TM
Anticancer Drugs; 2009 Sep; 20(8):659-67. PubMed ID: 19581798
[TBL] [Abstract][Full Text] [Related]
32. Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
Fokas E; Prevo R; Pollard JR; Reaper PM; Charlton PA; Cornelissen B; Vallis KA; Hammond EM; Olcina MM; Gillies McKenna W; Muschel RJ; Brunner TB
Cell Death Dis; 2012 Dec; 3(12):e441. PubMed ID: 23222511
[TBL] [Abstract][Full Text] [Related]
33. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
Raju U; Nakata E; Yang P; Newman RA; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):886-94. PubMed ID: 12377342
[TBL] [Abstract][Full Text] [Related]
34. Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer.
Tian J; Doi H; Saar M; Santos J; Li X; Peehl DM; Knox SJ
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1179-85. PubMed ID: 24210080
[TBL] [Abstract][Full Text] [Related]
35. Selective radiosensitization of human cervical cancer cells and normal cells by artemisinin through the abrogation of radiation-induced G2 block.
Gong XM; Zhang Q; Torossian A; Cao JP; Fu S
Int J Gynecol Cancer; 2012 Jun; 22(5):718-24. PubMed ID: 22552829
[TBL] [Abstract][Full Text] [Related]
36. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.
Nambiar DK; Rajamani P; Deep G; Jain AK; Agarwal R; Singh RP
Mol Cancer Ther; 2015 Dec; 14(12):2722-34. PubMed ID: 26516160
[TBL] [Abstract][Full Text] [Related]
37. Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization.
Maier P; Hartmann L; Wenz F; Herskind C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784176
[TBL] [Abstract][Full Text] [Related]
38. KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways.
Oommen D; Prise KM
Biochem Biophys Res Commun; 2012 May; 421(3):538-43. PubMed ID: 22521642
[TBL] [Abstract][Full Text] [Related]
39. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y
Crit Rev Oncol Hematol; 2015 Dec; 96(3):507-17. PubMed ID: 26253360
[TBL] [Abstract][Full Text] [Related]
40. Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells.
Bougen NM; Steiner M; Pertziger M; Banerjee A; Brunet-Dunand SE; Zhu T; Lobie PE; Perry JK
Endocr Relat Cancer; 2012 Oct; 19(5):625-44. PubMed ID: 22807498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
